Home
About
Overview
Sharing Data
ORCID
Help
History (101)
Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients.
Molecular targets for radiation oncology in prostate cancer.
Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer.
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies.
Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
See All 101 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
Weiss GJ. Doubling down with inhibitors of Notch and Hedgehog signaling pathways. J Thorac Oncol. 2012 Dec; 7(16 Suppl 5):S409-10.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Clinical Trials as Topic
Hedgehog Proteins
Humans
Lung Neoplasms
Molecular Targeted Therapy
Receptors, Notch
Signal Transduction
authors with profiles
Glen Weiss MD, MBA